Clene, Inc. (CLNN) PT Lowered to $19 at Oppenheimer, but Reiterated Optimism for CNM-Au8's Top-line Phase 2/3 results in ALS
Tweet Send to a Friend
Oppenheimer analyst Leland Gershell lowered the price target on Clene, Inc. (NASDAQ: CLNN) to $19.00 (from $20.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
